Skip to main content
ATR
NYSE Industrial Applications And Services

AptarGroup Tops Q2 Estimates, Guides Q3 EPS Above Consensus, and Unveils CEO Transition

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$137.25
Mkt Cap
$8.544B
52W Low
$103.227
52W High
$158.93
52W Position info
33% above low
Off High info
14% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

ATR sits 33% above its 52-week low of $103.227.

Summary

AptarGroup posted Q2 2026 adjusted EPS of $1.42 on record sales of $1.03B, beating consensus, and guided Q3 EPS to $1.45–$1.53, also above estimates. The company also announced that CEO Stephan Tanda will step down on September 1, with Gael Touya taking over.


Key Events · Earnings and Guidance · ATR

  • Q2 Earnings Beat

    Sales rose 6% to $1.03B, the first time above $1B, and adjusted EPS of $1.42 exceeded the $1.35 consensus. Core sales grew 1%.

  • Q3 Guidance Above Consensus

    Aptar guided Q3 adjusted EPS to $1.45–$1.53, above the $1.42 consensus, driven by expected solid growth across all segments.

  • CEO Transition Announced

    CEO Stephan Tanda will conclude his tenure on September 1, 2026, with Gael Touya assuming the role. The transition was framed as orderly and aligned with the company's outlook.

  • Shareholder Returns

    Aptar returned $81M in Q2 and $212M YTD through share repurchases (403K shares for $50M in Q2) and dividends ($0.48/share quarterly).


Analysis · ATR · Industrial Applications And Services

A clean Q2 beat saw AptarGroup's sales cross the $1 billion mark for the first time, with adjusted EPS of $1.42 coming in comfortably above the $1.35 consensus. The company's Q3 guidance of $1.45–$1.53 also landed ahead of expectations, signaling confidence in sustained momentum. Broad-based growth across all three segments marked the quarter, though product mix and operational factors compressed margins. Adding a leadership dimension to the earnings story, the filing disclosed that CEO Stephan Tanda will hand over to Gael Touya on September 1. The combination of a beat, above-consensus guidance, and a planned CEO change makes this a significant update for investors.

At the time of this filing, ATR was trading at $137.25 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $8.5B. The 52-week trading range was $103.23 to $158.93. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ATR - Latest Insights

ATR
Jul 30, 2026, 5:16 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $137.25
Real-time Price: $137.25 info
Change: $0 (0%) info
Market Cap: $8.544B info
ATR
Jul 30, 2026, 5:02 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $137.25
Real-time Price: $137.25 info
Change: $0 (0%) info
Market Cap: $8.544B info
ATR
Apr 30, 2026, 5:27 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $123.68
Real-time Price: $137.25 info
Change: +$13.57 (+11%) info
Market Cap: $8.544B info
ATR
Apr 30, 2026, 5:16 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $123.68
Real-time Price: $137.25 info
Change: +$13.57 (+11%) info
Market Cap: $8.544B info
ATR
Apr 30, 2026, 5:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $123.68
Real-time Price: $137.25 info
Change: +$13.57 (+11%) info
Market Cap: $8.544B info